跳至主要内容
临床试验/EUCTR2015-000089-72-IT
EUCTR2015-000089-72-IT进行中(未招募)1 期

FAT GENE EXPRESSION IN OVERWEIGHT AND OBESE PATIENTS WITH PERSISTENTLY ACTIVE RHEUMATOID ARTHRITIS TREATED WITH ABATACEPT AND CLINICAL RESPONSE

Policlinico Gemelli-CIC- UCSC0 个研究点目标入组 40 人开始时间: 2015年2月6日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Signed written Informed Consent
  • - RA patients with disease duration <12 months, in at least a moderately active disease state (DAS28 >3.2) despite MTX at the maximum tolerated doses (10-25 mg/week) and low doses of prednisone (<5 mg daily), stable since at least three months before enrolment (if necessary)
  • - Age: 18-70 years
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 35
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 5

排除标准

  • Hypersensitivity to the active substance or to any of the excipients
  • - Severe and uncontrolled infections such as sepsis and opportunistic infections
  • - Patients who are currently included in any interventional clinical trial in RA
  • - RA patients in therapy with other biologics

研究者

发起方
Policlinico Gemelli-CIC- UCSC

相似试验